| Autor: |
Karakasis P; Second Department of Cardiology, Aristotle University of Thessaloniki, General Hospital Hippokration, Thessaloniki, Greece. Electronic address: pakar15@hotmail.com., Patoulias D; Outpatient Department of Cardiometabolic Medicine, Aristotle University of Thessaloniki, General Hospital Hippokration, Greece., Giannakoulas G; First Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece., Rosenkranz S; Clinic III for Internal Medicine (Department of Cardiology, Pulmonology and Intensive Care Medicine), and Cologne Cardiovascular Research Center (CCRC), Heart Center at the University Hospital Cologne, Köln, Germany., Fragakis N; Second Department of Cardiology, Aristotle University of Thessaloniki, General Hospital Hippokration, Thessaloniki, Greece. |
| Jazyk: |
angličtina |
| Zdroj: |
European journal of internal medicine [Eur J Intern Med] 2024 Jun; Vol. 124, pp. 147-149. Date of Electronic Publication: 2024 Mar 08. |
| DOI: |
10.1016/j.ejim.2024.03.003 |
| Abstrakt: |
Competing Interests: Declaration of competing interest G.G. has received fees for lectures and/or consultation from Actelion, Bayer, ELPEN Pharmaceuticals, Galenica, GlaxoSmithKline, Janssen, MSD, Pfizer, Lilly, and United Therapeutics. S.R. has received fees for lectures and/or consultations from Abbott, Acceleron, Actelion, Aerovate, Altavant, AOP Orphan, AstraZeneca, Bayer, Boehringer Ingelheim, Edwards, Ferrer, Gossamer, Janssen, MSD, United Therapeutics, and Vifor; his institution has received research grants from Actelion, AstraZeneca, Bayer, and Janssen. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect